Infectious diseases (London, England)

Viral particles do not contribute significantly to serum levels of hepatitis B surface antigen which is produced mainly from integrated HBV DNA in most patients with chronic hepatitis B.

Pub Date : 2025-09-11 DOI: 10.1080/23744235.2025.2555899 Anders Eilard, Gustaf E Rydell, Joakim Bedner Stenbäck, Johan Ringlander, Magnus Lindh

Pooled data from phase 3 clinical trials comparing the clinical activity of ceftolozane/tazobactam versus meropenem for the treatment of complicated intra-abdominal infections.

Pub Date : 2025-09-06 DOI: 10.1080/23744235.2025.2544828 Zhiqiang Li, Yue Kang, Hongqiang Gao, Yingpeng Zhao, Ding Luo, Dongdong Wang, Xiang Zhang, Jieqi Yu, Guang Chu, Jun Cao, Fan Wang, Xiongqi Zhao, Erin Jensen, Gina Lin, Gang Chen

Activity of sotrovimab in early clearance of SARS CoV-2 infection in severe immunocompromised patients: results of a prospective, monocentric study.

Pub Date : 2025-09-05 DOI: 10.1080/23744235.2025.2553664 Giulio Viceconte, Antonio Riccardo Buonomo, Emilia Trucillo, Alessia D'Agostino, Daria Pietroluongo, Alessia Sardanelli, Letizia Cattaneo, Maria Foggia, Salvatore di Bernardo, Francesco Grimaldi, Mario Annunziata, Ivan Gentile